Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction

@inproceedings{Zhao2013IntracoronaryFD,
  title={Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction},
  author={Yu-jun Zhao and Xiang-hua Fu and Xiao-Xiao Ma and Dong-ying Wang and QIU-LI DONG and Yanbo Wang and Wei Li and Kun Xing and Xin-shun Gu and Yun-fa Jiang},
  booktitle={Experimental and therapeutic medicine},
  year={2013}
}
Previous studies have shown that intracoronary (IC) nitroprusside (NTP) injection is a safe and effective strategy for the treatment of no-reflow (NR) during percutaneous coronary intervention (PCI). The present study tested the hypothesis that, on the basis of thrombus aspiration for the treatment of ST-segment elevation myocardial infarction (STEMI), the selective IC administration of a fixed dose of NTP (100 μg) plus tirofiban is a safe and superior treatment method compared with the IC… CONTINUE READING
5 Citations
25 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-5 of 5 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

The use of intracoronary sodium nitroprusside to treat no ‐ reflow after primary percutaneous coronary intervention in acute myocardial infarction

  • MB Tesic, G Stankovic, V Vukcevic, MC Ostojic
  • Herz
  • 2010

Similar Papers

Loading similar papers…